Chrishan Samuel

20PUBLICATIONS
38CO-AUTHORS
MechanobiologyMolecular targetsRegenerative medicine (incl. stem cells)AutoimmunityProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 17, 2026
Therapeutic targeting of bleomycin-induced pulmonary fibrosis by human bone marrow mesenchymal stem cell-derived extracellular vesicles and/or pirfenidone: Impact of sex in mature adult mice.

|Jul 01, 2025
The novel AT2 receptor ligand, β-Pro7 Ang III, induces equivalent anti-fibrotic effects to Compound 21 but broader anti-fibrotic effects than pirfenidone in mice with bleomycin-induced pulmonary fibrosis.

Simon G Royce, Cem Erdem, WeiYi Mao

|Oct 24, 2024
The renoprotective efficacy and safety of genetically-engineered human bone marrow-derived mesenchymal stromal cells expressing anti-fibrotic cargo.

Yifang Li, Alex Hunter, Miqdad M Wakeel

|Apr 13, 2023
A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity.

Praveen Praveen, Chao Wang, Thomas N G Handley

|Jan 30, 2023
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis.

Udari Eshani Perera, Louise Organ, Simon G Royce

|Dec 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis.

Chrishan S Samuel, Yifang Li, Yan Wang

Pageof 4

Frequent Collaborators

3 joint publications

Yan Wang

3 joint publications

Robert E Widdop

2 joint publications

Simon Royce

2 joint publications

Yifang Li